Feasibility in France of a Mindfulness-based Group Therapy for Adolescents With Chronic Pain (PEACEFULL)

November 21, 2025 updated by: University Hospital, Toulouse
The main objective is to study the feasibility of a program for the management of chronic painful adolescents in meditation groups. This program is an adaptation of the MBI-A (Mindfulness-based intervention for adolescent) program developed in another socio-cultural context (i.e. in Canada). The secondary objectives will be to study the effect of a mindfulness meditation program for adolescents on pain, quality of life, acceptance of pain, functional disability, catastrophism, anxiety-depression, emotional repercussions and acceptance of mindfulness

Study Overview

Status

Completed

Conditions

Detailed Description

Paediatric chronic pain can lead to serious consequences in terms of daily functioning (school absenteeism and loss of social interactions) and global quality of life. Mindfulness-based interventions (MBI's) approaches which emphasize acceptance rather than control of pain have gained increasing attention in adults with chronic pain. The effectiveness of MBI's for chronic pain in paediatric population remains largely unknown. An MBI program for adolescent was conducted in Toronto's Hospital for Sick Children and happened to be feasible and well received for adolescents with chronic pain conditions. The aim of the present program is to study the feasibility in France of a mindfulness program dedicated for adolescents with chronic pain.

An eight-session, two hour Mindfulness Based Intervention dedicated to adolescents will be provided. The intervention will focus on skill building and will incorporate mindfulness meditation, exercises and activities specially adapted to teenagers with chronic pain. Topics will include mind body connection, the effect of stress on pain, living in the present moment, focused awareness, responding versus reacting to pain and/ or difficult situations, non judgement, gratitude, kindness and compassion towards self and others.

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Toulouse, France, 31059
        • Hopital des Enfants

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 17 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Teenagers from 12 to 17 years of age followed at the Children's Hospital of Toulouse, as part of the Multidisciplinary Consultation of Pain
  • including French.
  • With the consent of the teenager and the parents
  • Affiliated person or beneficiary of a social security scheme.

Exclusion Criteria:

  • intellectual deficit not allowing to participate in a meditation program
  • participating in research involving body therapies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mindfulness program
To study the feasibility in France of a mindfulness program with mindfulness-based interventions (MBI's) dedicated for adolescents with chronic pain.
Mindfulness Based Intervention with eight sessions (one session per week) of two hours dedicated to adolescents will be provided. The intervention will focus on skill building and will incorporate mindfulness meditation, exercises and activities specially adapted to teenagers with chronic pain. Topics will include mind body connection, the effect of stress on pain, living in the present moment, focused awareness, responding versus reacting to pain and/ or difficult situations, non judgement, gratitude, kindness and compassion towards self and others.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility in France of a mindfulness program : percentage of adolescents who will attend at least 6 of the 8 sessions
Time Frame: End of the mindfulness program (8 weeks)
The primary outcome will be the percentage of adolescents who will attend at least 6 of the 8 sessions.
End of the mindfulness program (8 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attendance rate
Time Frame: 1st session of the program (T1 week)
Percentage of adolescents present at each program session
1st session of the program (T1 week)
Attendance rate
Time Frame: 2nd session of the program (T2 weeks)
Percentage of adolescents present at each program session
2nd session of the program (T2 weeks)
Attendance rate
Time Frame: 3rd session of the program (T3 weeks)
Percentage of adolescents present at each program session
3rd session of the program (T3 weeks)
Attendance rate
Time Frame: 4th session of the program (T4 weeks)
Percentage of adolescents present at each program session
4th session of the program (T4 weeks)
Attendance rate
Time Frame: 5th session of the program (T5 weeks)
Percentage of adolescents present at each program session
5th session of the program (T5 weeks)
Attendance rate
Time Frame: 6th session of the program (T6 weeks)
Percentage of adolescents present at each program session
6th session of the program (T6 weeks)
Attendance rate
Time Frame: 7th session of the program (T7 weeks)
Percentage of adolescents present at each program session
7th session of the program (T7 weeks)
Attendance rate
Time Frame: 8th session of the program (T8 weeks)
Percentage of adolescents present at each program session
8th session of the program (T8 weeks)
Punctuality at the session
Time Frame: 1st session of the program (T1 week)
binary criterion yes/no
1st session of the program (T1 week)
Punctuality at the session
Time Frame: 2nd session of the program (T2 weeks)
binary criterion yes/no
2nd session of the program (T2 weeks)
Punctuality at the session
Time Frame: 3rd session of the program (T3 weeks)
binary criterion yes/no
3rd session of the program (T3 weeks)
Punctuality at the session
Time Frame: 4th session of the program (T4 weeks)
binary criterion yes/no
4th session of the program (T4 weeks)
Punctuality at the session
Time Frame: 5th session of the program (T5 weeks)
binary criterion yes/no
5th session of the program (T5 weeks)
Punctuality at the session
Time Frame: 6th session of the program (T6 weeks)
binary criterion yes/no
6th session of the program (T6 weeks)
Punctuality at the session
Time Frame: 7th session of the program (T7 weeks)
binary criterion yes/no
7th session of the program (T7 weeks)
Punctuality at the session
Time Frame: 8th session of the program (T8 weeks)
binary criterion yes/no
8th session of the program (T8 weeks)
Treatment acceptability
Time Frame: inclusion visit
Rate of eligible adolescents who agreed to participate in the study
inclusion visit
Treatment acceptability
Time Frame: 2nd session of the program (T2 weeks)
Daily practice at home (binary criterion yes/no)
2nd session of the program (T2 weeks)
Treatment acceptability
Time Frame: 3rd session of the program (T3 weeks)
Daily practice at home (binary criterion yes/no)
3rd session of the program (T3 weeks)
Treatment acceptability
Time Frame: 4th session of the program (T4 weeks)
Daily practice at home (binary criterion yes/no)
4th session of the program (T4 weeks)
Treatment acceptability
Time Frame: 5th session of the program (T5 weeks)
Daily practice at home (binary criterion yes/no)
5th session of the program (T5 weeks)
Treatment acceptability
Time Frame: 6th session of the program (T6 weeks)
Daily practice at home (binary criterion yes/no)
6th session of the program (T6 weeks)
Treatment acceptability
Time Frame: 7th session of the program (T7 weeks)
Daily practice at home (binary criterion yes/no)
7th session of the program (T7 weeks)
Treatment acceptability
Time Frame: 8th session of the program (T8 weeks)
Daily practice at home (binary criterion yes/no)
8th session of the program (T8 weeks)
Pain Level
Time Frame: Inclusion visit (baseline)
Pain level will be assessed using Visual Analog Scale (from 0 "no pain" to 10 "the worst pain possible "). The pain will be measured by the average of the visual analogue rating scales evaluated over the last 8 days.
Inclusion visit (baseline)
Pain Level
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Pain level will be assessed using Visual Analog Scale (from 0 "no pain" to 10 "the worst pain possible "). The pain will be measured by the average of the visual analogue rating scales evaluated over the last 8 days.
T2 Visit (1 week after the end of the 8-week program)
Pain Level
Time Frame: T3 Visit (3 months after the end of the 8-week program)
Pain level will be assessed using Visual Analog Scale (from 0 "no pain" to 10 "the worst pain possible "). The pain will be measured by the average of the visual analogue rating scales evaluated over the last 8 days.
T3 Visit (3 months after the end of the 8-week program)
Quality of life at the end of program
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Quality of life will be assessed using the french scale VSPA-12 ("Vécu et Santé Perçue de l'adolescent - 12 items", "Lived and Health Perceived in 12 items) which is a self-questionnaire to assess the impact of adolescents health on their everyday life. The 12 items have five possible answers: never, rarely, sometimes, often, always.
T2 Visit (1 week after the end of the 8-week program)
Quality of life in long term
Time Frame: T3 Visit (3 months after the end of the 8-week program)
Quality of life will be assessed using the french scale VSPA-12 ("Vécu et Santé Perçue de l'adolescent - 12 items", "Lived and Health Perceived in 12 items) which is a self-questionnaire to assess the impact of adolescents health on their everyday life. The 12 items have five possible answers: never, rarely, sometimes, often, always.
T3 Visit (3 months after the end of the 8-week program)
Chronic pain acceptance
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Chronic pain acceptance will be assessed using CPAQ-A (Chronic Pain Acceptance Questionnaire, Adolescent version) translated in French. CPAQ-A (Questionnaire for acceptance of chronic pain for adolescents) has 20 items For each item, the answer modalities are: 0= Never True, 1 = Rarely true, 2 = sometimes true, 3 = Often true, 4 = always true.
T2 Visit (1 week after the end of the 8-week program)
Chronic pain acceptance
Time Frame: T3 Visit (3 months after the end of the 8-week program)
Chronic pain acceptance will be assessed using CPAQ-A (Chronic Pain Acceptance Questionnaire, Adolescent version) translated in French. CPAQ-A (Questionnaire for acceptance of chronic pain for adolescents) has 20 items For each item, the answer modalities are: 0= Never True, 1 = Rarely true, 2 = sometimes true, 3 = Often true, 4 = always true.
T3 Visit (3 months after the end of the 8-week program)
Functional disability
Time Frame: Inclusion visit (baseline)
Functional disability will be assessed using FDI (Functional Disability Inventory) which is a functional disability scale to assess physical problems or any difficulties that adolescents may have in performing activities of daily living. FDI have 15 items. For each item, the answer modalities are 0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble and 4 = impossible. The total FDI score is a sum of all of the items. The FDI score ranges from 0 to 60, with higher score indicating greater functional disability.
Inclusion visit (baseline)
Functional disability
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Functional disability will be assessed using FDI (Functional Disability Inventory) which is a functional disability scale to assess physical problems or any difficulties that adolescents may have in performing activities of daily living. FDI have 15 items. For each item, the answer modalities are 0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble and 4 = impossible. The total FDI score is a sum of all of the items. The FDI score ranges from 0 to 60, with higher score indicating greater functional disability.
T2 Visit (1 week after the end of the 8-week program)
Functional disability
Time Frame: T3 Visit (3 months after the end of the 8-week program)
Functional disability will be assessed using FDI (Functional Disability Inventory) which is a functional disability scale to assess physical problems or any difficulties that adolescents may have in performing activities of daily living. FDI have 15 items. For each item, the answer modalities are 0 = no trouble, 1 = a little trouble, 2 = some trouble, 3 = a lot of trouble and 4 = impossible. The total FDI score is a sum of all of the items. The FDI score ranges from 0 to 60, with higher score indicating greater functional disability.
T3 Visit (3 months after the end of the 8-week program)
Anxiety and Depression
Time Frame: Inclusion visit (baseline)
The anxiety and depression will be assessed using the french version of the Revised Children's Anxiety and Depression Scale (RCADS) intended to evaluate the symptomatology associated with anxiety disorders and major depression in children. This scale have 29 items. For each item, the possible answers are: never, sometimes, often, always.
Inclusion visit (baseline)
Anxiety and Depression
Time Frame: T2 Visit (1 week after the end of the 8-week program)
The anxiety and depression will be assessed using the french version of the Revised Children's Anxiety and Depression Scale (RCADS) intended to evaluate the symptomatology associated with anxiety disorders and major depression in children. This scale have 29 items. For each item, the possible answers are: never, sometimes, often, always.
T2 Visit (1 week after the end of the 8-week program)
Anxiety and Depression
Time Frame: T3 Visit (3 months after the end of the 8-week program)
The anxiety and depression will be assessed using the french version of the Revised Children's Anxiety and Depression Scale (RCADS) intended to evaluate the symptomatology associated with anxiety disorders and major depression in children. This scale have 29 items. For each item, the possible answers are: never, sometimes, often, always.
T3 Visit (3 months after the end of the 8-week program)
Catastrophism
Time Frame: Inclusion visit (baseline)
Catastrophism will be assessed using PCS-Ado (Pain Catastrophizing Scale for Francophone Adolescents) which identifies the thoughts and emotions that may be associated with the pain. PCS-Ado have 13 items. For each item, the possible answers are: never, rarely, sometimes, often and always.
Inclusion visit (baseline)
Catastrophism
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Catastrophism will be assessed using PCS-Ado (Pain Catastrophizing Scale for Francophone Adolescents) which identifies the thoughts and emotions that may be associated with the pain. PCS-Ado have 13 items. For each item, the possible answers are: never, rarely, sometimes, often and always.
T2 Visit (1 week after the end of the 8-week program)
Catastrophism
Time Frame: T3 Visit (3 months after the end of the 8-week program)
Catastrophism will be assessed using PCS-Ado (Pain Catastrophizing Scale for Francophone Adolescents) which identifies the thoughts and emotions that may be associated with the pain. PCS-Ado have 13 items. For each item, the possible answers are: never, rarely, sometimes, often and always.
T3 Visit (3 months after the end of the 8-week program)
Mindfulness acceptance
Time Frame: Inclusion visit (baseline)
Mindfulness acceptance will be assessed using the French version of Five Facets Mindfulness Questionnaire (FFMQ) with 39 items. For each item the possible answers are: 1 = never or very rarely true, 2 = rarely true, 3 = sometimes true, 4 = often true, 5 = very often or always true.
Inclusion visit (baseline)
Mindfulness acceptance
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Mindfulness acceptance will be assessed using the French version of Five Facets Mindfulness Questionnaire (FFMQ) with 39 items. For each item the possible answers are: 1 = never or very rarely true, 2 = rarely true, 3 = sometimes true, 4 = often true, 5 = very often or always true.
T2 Visit (1 week after the end of the 8-week program)
Mindfulness acceptance
Time Frame: T3 Visit (3 months after the end of the 8-week program)
Mindfulness acceptance will be assessed using the French version of Five Facets Mindfulness Questionnaire (FFMQ) with 39 items. For each item the possible answers are: 1 = never or very rarely true, 2 = rarely true, 3 = sometimes true, 4 = often true, 5 = very often or always true.
T3 Visit (3 months after the end of the 8-week program)
Strengths and Difficulties
Time Frame: Inclusion visit (baseline)
Strengths and difficulties will be assessed using the french version of the Strengths and Difficulties Questionnaire (SDQ-Fra) with 25 items. For each item, the possible answers are : not true, a little true, very true. The total difficulty score of the SDQ ranges from 0-40.
Inclusion visit (baseline)
Strengths and Difficulties
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Strengths and difficulties will be assessed using the french version of the Strengths and Difficulties Questionnaire (SDQ-Fra) with 25 items. For each item, the possible answers are : not true, a little true, very true. The total difficulty score of the SDQ ranges from 0-40.
T2 Visit (1 week after the end of the 8-week program)
Strengths and Difficulties
Time Frame: T3 Visit (3 months after the end of the 8-week program)
Strengths and difficulties will be assessed using the french version of the Strengths and Difficulties Questionnaire (SDQ-Fra) with 25 items. For each item, the possible answers are : not true, a little true, very true. The total difficulty score of the SDQ ranges from 0-40.
T3 Visit (3 months after the end of the 8-week program)
Adolescents satisfaction
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Adolescents satisfaction about the mindfulness program will be assessed using a satisfaction questionnaire with 8 items designed for this study. For each item, the modality answers are scored from 1 to 4.
T2 Visit (1 week after the end of the 8-week program)
Parents satisfaction
Time Frame: T2 Visit (1 week after the end of the 8-week program)
Parents satisfaction about the mindfulness program followed by their children will be assessed using a satisfaction questionnaire with 8 items designed for the study.
T2 Visit (1 week after the end of the 8-week program)
Quality of life at baseline : impact of adolescents health on their everyday life.
Time Frame: Inclusion visit (baseline)
Quality of life will be assessed using the french scale VSPA-12 ("Vécu et Santé Perçue de l'adolescent (VSPA) - 12 items", "Lived and Health Perceived in 12 items) which is a self-questionnaire to assess the impact of adolescents health on their everyday life. The 12 items have five possible answers: never, rarely, sometimes, often, always.
Inclusion visit (baseline)
Chronic pain acceptance
Time Frame: Inclusion visit (baseline)
Chronic pain acceptance will be assessed using Chronic Pain Acceptance Questionnaire, Adolescent version (CPAQ-A) translated in French. CPAQ-A has 20 items For each item, the answer modalities are: 0= Never True, 1 = Rarely true, 2 = sometimes true, 3 = Often true, 4 = always true.
Inclusion visit (baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Agnès SUC, MD, University Hospital, Toulouse

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2018

Primary Completion (Actual)

March 31, 2021

Study Completion (Actual)

March 31, 2021

Study Registration Dates

First Submitted

April 27, 2018

First Submitted That Met QC Criteria

June 6, 2018

First Posted (Actual)

June 19, 2018

Study Record Updates

Last Update Posted (Estimated)

November 28, 2025

Last Update Submitted That Met QC Criteria

November 21, 2025

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RC31/17/0354
  • 2017-A03338-45 (Other Identifier: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on Mindfulness-based interventions (MBI's)

Subscribe